Do Analysts Think ATRenew Inc ADR (RERE) Is Still Worth Buying In 2024?

ATRenew Inc ADR (NYSE:RERE) does about 1.13M shares in volume on a normal day but saw 1563698 shares change hands in the recent trading day. The company now has a market cap of 300.25M USD. Its current market price is $2.28, marking no change compared to the previous close of $2.28. The 52 week high reached by this stock is $3.03 whilst the lowest price level in 52 weeks is $1.01.

ATRenew Inc ADR (RERE) has a 20-day trading average at $2.58 and the current price is -24.63% off the 52-week high compared with 125.74% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.42 and its 200-day simple moving average is $1.90. If we look at the stock’s price movements over the week, volatility stands at 8.23%, which decreases to 6.46% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 40.25 to suggest the stock is neutral.

The consensus objective for the share price is $3.16, suggesting that the stock has a potential upside of 27.85% over the period.

FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 1 analysts have rated it as a sell, while 0 advise that it is a overweight. 0 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Sell and Wall Street’s advice is for investors to Strong Buy the stock.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on July 15, 2021 when BofA Securities initiated the stock to “Buy” and issued a price target of $20.

The current price level is -11.82%, -6.08%, and 20.09% away from its SMA20, SMA50, and SMA200 respectively, with the RERE price moving above the 50-day SMA on current market day. ATRenew Inc ADR (RERE) stock is down -19.72% over the week and -10.24% over the past month. Its price is 18.75% year-to-date and 0.00% over the past year.

The stock last released its quarterly earnings report for quarter ended 6/30/2024, with the company’s earnings per share (EPS) of 0.04 above consensus estimates by 0.01. The company’s next earnings report forecasts estimating quarterly EPS at 0.08 and 0.25 for whole year. Expected sales for next quarter are $642.77M, which analysts say will come at $2.25B for the current fiscal year and next year at $2.82B. In addition, estimates put the company’s current quarterly revenue at an average of $563.86M.

To reach the target analysts have set, the stock logically needs to grow 27.85 percent from here.

Outstanding shares total 131.70M with insiders holding 2.66% of the shares and institutional holders owning 26.01% of the company’s common stock. The company has a return on investment of -3.99% and return on equity of -3.93%. The forward price to earnings ratio is 13.71. The beta has a value of -0.19. Price to book ratio is 1.00 and price to sales ratio is 0.15.